Research in the Driskell group focuses on the development of novel diagnostic and biological assays by interfacing chemistry, nanomaterials, and biology. Work includes both applied research to develop innovative bioanalytical tools, as well as fundamental research to investigate the mechanism of SERS, antibody-antigen binding kinetics, and novel ligands.